BEIJING, Jan. 8, 2016 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its wholly-owned subsidiary, Meizhong Jiahe Hospital Management Corp. Ltd ("MHM"), formerly known as CMS Hospital Management Co., Ltd, has received approval from the National Equities Exchange and Quotations ("NEEQ") in China to list its shares on the New Third Board, the over-the-counter (OTC) stock exchange in China. Concord Medical is currently performing relevant procedures prior to listing.
MHM provides management services to the Company's existing network of radiotherapy and diagnostic imaging centers. MHM is implementing plans to build and operate a network of cancer specialty hospitals and free-standing radiotherapy and diagnostic imaging centers in China.
The New Third Board or NEEQ is a national over-the-counter stock exchange established by the State Council in 2012 in Beijing, regulated by the China Securities Regulatory Commission, and managed by NEEQ. It serves as a platform for the sale of existing shares or directed share placements and has become an increasingly popular financing platform for companies. According the official website of NEEQ, as of December 31, 2015, there are 5,129 companies listed on the New Third Board.
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of September 30, 2015, the Company operated a network of 127 centers with 76 hospital partners that spanned 53 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. As part of its high-end cancer hospital development strategy and oversea business extension, the Company acquired Concord Cancer Hospital, a private hospital in Singapore in April, 2015. For more information, please see http://ir.concordmedical.com.
For more information, please contact:
Concord Medical Services Mr. Adam J. Sun (Chinese and English) +86 10 5957 5266 firstname.lastname@example.org
Ms. Fang Liu (Chinese and English) +86 10 5903 6688 (ext. 639) email@example.com
SOURCE Concord Medical Services Holdings Limited